[HTML][HTML] Economic evaluation of COVID-19 vaccination: A systematic review

AM Utami, F Rendrayani, QA Khoiry… - Journal of global …, 2023 - ncbi.nlm.nih.gov
Background Safe and effective vaccination is considered to be the most critical strategy to
fight coronavirus disease 2019 (COVID-19), leading to individual and herd immunity …

Protection against SARS-CoV-2 Omicron BA. 4/5 variant following booster vaccination or breakthrough infection in the UK

J Wei, PC Matthews, N Stoesser, JN Newton… - Nature …, 2023 - nature.com
Following primary SARS-CoV-2 vaccination, whether boosters or breakthrough infections
provide greater protection against SARS-CoV-2 infection is incompletely understood. Here …

Cost‐effectiveness of COVID‐19 vaccination: A systematic review

Y Fu, J Zhao, P Han, J Zhang, Q Wang… - Journal of Evidence …, 2023 - Wiley Online Library
Objective The COVID‐19 vaccination strategy has been widely used to protect population
health worldwide. This study aims to summarize the cost‐effectiveness evidence of …

Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study

RK Mohapatra, S Mishra, V Kandi… - Health Science …, 2023 - Wiley Online Library
Abstract Background and Aim Understanding the prevalence and impact of SARS‐CoV‐2
variants has assumed paramount importance. This study statistically analyzed to effectively …

How prevalent is COVID-19 vaccine hesitancy in low-income and middle-income countries and what are the key drivers of hesitancy? Results from 53 countries

JD Eberwein, IN Edochie, D Newhouse, A Cojocaru… - BMJ open, 2023 - bmjopen.bmj.com
Objectives This study aims to estimate the levels of COVID-19 vaccine hesitancy in 53 low-
income and middle-income countries, differences across population groups in hesitancy …

[PDF][PDF] COVID-19 vaccine hesitancy in 53 developing countries: levels, trends, and reasons for hesitancy

JD Eberwein, I Edochie, D Newhouse, A Cojocaru… - 2021 - documents1.worldbank.org
This paper presents new evidence on the levels and trends of vaccine hesitancy in
developing countries based on harmonized high frequency phone surveys (HFPS) from over …

International Partnerships to Develop Evidence-informed Priority Setting Institutions: Ten Years of Experience from the International Decision Support Initiative (iDSI)

P Baker, E Barasa, K Chalkidou, L Chola… - Health Systems & …, 2023 - Taylor & Francis
All health systems must set priorities. Evidence-informed priority-setting (EIPS) is a specific
form of systematic priority-setting which involves explicit consideration of evidence to …

Qualitative conceptual content analysis of COVID-19 vaccine administration error inquiries

E Hall, S Odafe, J Madden, S Schillie - Vaccines, 2023 - mdpi.com
The launch of the COVID-19 vaccination program was the largest vaccination campaign in
US history, with an unprecedented demand for vaccine and new vaccination providers …

What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria

FJ Ruiz, S Torres-Rueda, CAB Pearson… - PLOS global public …, 2023 - journals.plos.org
While safe and efficacious COVID-19 vaccines have achieved high coverage in high-income
settings, roll-out remains slow in sub-Saharan Africa. By April 2022, Nigeria, a country of …

Cost-effectiveness analysis of vaccination against COVID-19 in China

H Zhou, N Ding, X Han, H Zhang, Z Liu, X Jia… - Frontiers in Public …, 2023 - frontiersin.org
Introduction Since September 2020, Chinese populations aged> 3 years have been
encouraged to receive a two-dose inoculation with vaccines against coronavirus disease …